CT Coronary Angiogram (CTCA) vs Calcium Score Explained
%20vs%20Calcium%20Score%20Explained.avif)
A CT coronary angiogram (CTCA) and a coronary artery calcium score are often described as “heart scans”, but they answer different questions. A calcium score measures calcified plaque in the coronary arteries to help refine cardiovascular risk. CT coronary angiography uses contrast-enhanced CT images to examine both calcified and non-calcified plaque, as well as narrowing of the coronary arteries.
That distinction matters whether you are considering preventive assessment because of a family history of heart disease or seeing a doctor about chest pain. Neither test is the right choice for everyone, and choosing more imaging does not necessarily lead to better health outcomes.
Everlab offers CTCA as part of its cardiovascular assessment pathway and includes coronary calcium scoring as part of that imaging package. Your Everlab doctor should first establish whether imaging is appropriate for your symptoms, risk factors and clinical circumstances.
This information complements, and does not replace, advice from your treating doctor. Imaging involves radiation exposure, and CTCA also uses iodinated contrast. A referral is required for Everlab's CTCA service.
The Core Difference: CTCA vs Calcium Score
Both are cardiac CT tests that use X-rays to create images. A CT calcium score is usually a brief, non-contrast examination. CTCA involves more preparation and contrast dye to make the lumen, or inner channel, of the coronary arteries visible. The choice is clinical, not simply a question of which test is more comprehensive.
What Is a Coronary Artery Calcium Score?
Coronary artery calcium scoring, sometimes called a coronary calcium scan or CT calcium score, measures calcium within atherosclerotic plaque in the walls of the heart's arteries. It uses a low-dose, non-contrast computed tomography scan. No intravenous contrast or cannula is required for a standard calcium score test.
Calcium can develop as coronary atherosclerosis progresses. A higher score generally indicates a greater burden of calcified coronary plaque and is associated with a higher risk of future cardiovascular events at the population level.
The result is reported in Agatston units (AU). The Agatston score combines the extent and density of detectable coronary calcification. It does not measure how much non-calcified plaque is present, or precisely how much an artery is narrowed.
What a Calcium Score Can Tell You
A coronary artery calcium test may help a clinician:
- Identify detectable calcified plaque in the coronary arteries.
- Refine an estimate of future cardiovascular risk when traditional risk factors leave uncertainty.
- Discuss whether cholesterol-lowering therapy, blood pressure management or other preventive treatment is appropriate.
- Consider the result alongside blood cholesterol, diabetes, smoking, blood pressure and family history.
It is primarily a risk assessment tool, rather than a diagnostic test for determining the cause of current chest pain.
What a Calcium Score Cannot Tell You
Calcium scoring cannot show non-calcified plaque, often called soft plaque, and cannot reliably establish stenosis severity. A person can have a calcium score of zero and still have non-calcified coronary plaque, particularly at younger ages.
Likewise, a high coronary calcium score does not prove that an artery has a flow-limiting blockage. The amount of calcified plaque and the degree of narrowing are related but distinct features of coronary disease. These limits are important when comparing coronary artery calcium scoring with CTCA.
Who Should Consider a Calcium Score?
Australian clinical practice guidelines do not recommend coronary artery calcium scoring as a general population screening test. It may be considered selectively when the result could change a preventive treatment decision.
The 2023 Australian guideline for assessing and managing cardiovascular disease risk recommends starting with an overall risk assessment, usually using the Australian CVD Risk Calculator. This considers traditional risk factors and relevant clinical information rather than imaging everyone of a particular age.
A calcium score may then help when:
- Estimated cardiovascular risk is low or intermediate, but there are additional concerns not fully captured by the risk calculator.
- A person has a strong family history of early heart disease or other risk-enhancing factors.
- A decision about starting or intensifying lipid-lowering therapy is genuinely uncertain.
- The clinician and patient agree that knowing the calcium score is likely to change management.
The Heart Foundation's 2021 Australian position statement also supports selective use in some people at moderate risk, or at low calculated risk with additional risk-enhancing factors. Its recommendations are conditional and are not an instruction to scan everyone with a family history or elevated blood pressure.
Should Men Over 40 or Women Over 45 Have a Calcium Scan?
Some international guidance discusses age ranges such as men aged 40 years and older and women aged 45 years and older in the context of coronary calcium testing. Age alone is not an Australian recommendation to undergo the scan.
For an Australian patient, a Heart Health Check, cardiovascular risk calculation and shared decision-making with a doctor are the appropriate starting points. A calcium score may be useful for some people and unnecessary for others.
When Calcium Scoring Is Less Useful
The 2023 Australian guideline advises against using coronary calcium scoring to refine preventive cardiovascular risk in people with known coronary heart disease, a previous heart attack or coronary revascularisation, or those already known to be at high cardiovascular risk. In these circumstances, treatment decisions generally do not depend on the calcium result.
A calcium score should also not be used to explain new chest pain, substitute for a clinical assessment or reassure someone with concerning symptoms that no further evaluation is needed.
How Is a Coronary Calcium Score Interpreted?
A coronary calcium score is commonly reported using the following Agatston categories:
These categories describe calcified plaque burden, not an individual's precise chance of having a heart attack. Risk also depends on age, sex, diabetes, smoking, family history, blood pressure, blood cholesterol and other factors.
A score may additionally be compared with people of the same age and sex using a percentile. A score that is high for someone's age can be clinically important even if the absolute number is not especially large.
Does a Calcium Score of Zero Rule Out Heart Disease?
No. A zero score means the scan found no detectable calcified plaque. It does not mean there is no coronary artery disease, no non-calcified plaque, or no possibility of a future heart attack.
The result can still be reassuring in selected people without symptoms. However, the Heart Foundation recommends caution where other risk-enhancing factors exist, including diabetes, smoking and a strong family history.
What Does a High Calcium Score Mean?
Higher calcium scores indicate increasing coronary plaque burden and can support changes to preventive care. For example, the Heart Foundation's position statement suggests that a score above 99 AU, or at or above the 75th percentile for age and sex, may justify reclassifying some patients to a higher cardiovascular risk category.
This is not an automatic rule for every patient. The treating clinician should interpret the score alongside the person's overall estimated risk, symptoms and treatment preferences. A high calcium score also does not, by itself, mean that a stent, bypass surgery or invasive coronary angiography is required.
What Is CT Coronary Angiography (CTCA)?
CT coronary angiography, also called a CT coronary angiogram or coronary CTA, uses a cardiac CT scanner and an iodine-based contrast injection to create detailed images of the coronary arteries.
Unlike a standalone coronary calcium scan, CTCA can visualise both calcified and non-calcified plaque and assess the degree of narrowing, known as stenosis. This makes it useful when a doctor needs information about suspected coronary artery disease rather than only a risk marker.
CTCA is less invasive than conventional invasive coronary angiography because it does not involve inserting a catheter into an artery. It still involves intravenous access, ionising radiation, contrast exposure and screening for suitability.
What CTCA Can Detect
Depending on scan quality and the clinical indication, a CT coronary angiogram may help assess:
- Coronary plaque, including calcified, non-calcified and mixed plaque.
- Narrowing in the coronary arteries and its estimated severity.
- The pattern and distribution of coronary atherosclerosis.
- Some congenital coronary artery anomalies.
- Selected bypass grafts and other coronary anatomy in appropriate clinical scenarios.
CTCA images show how contrast fills the coronary arteries and help identify potential narrowing. They do not directly measure coronary blood flow. A further functional test may be needed to establish whether a narrowing is limiting blood supply to the heart muscle.
CTCA in People With Chest Pain
CTCA is commonly considered when someone has symptoms that could indicate coronary artery disease, such as stable chest pain, and when the clinical assessment supports its use. A clinician may choose CTCA, a stress test, other cardiac imaging or, in some cases, invasive coronary angiography. The appropriate test depends on symptoms, risk level, other findings and the possibility of an urgent condition.
New, severe or persistent chest pain may require emergency assessment. CTCA arranged through a preventive health service is not a substitute for urgent evaluation of a possible heart attack.
When CTCA May Be Less Suitable
CTCA is not equally useful for everyone. Scan quality or clinical suitability may be affected by factors including:
- Extensive coronary calcification that makes narrowing difficult to assess.
- An irregular or very rapid heart rate.
- A previous reaction to iodinated contrast.
- Some forms of significant kidney impairment.
- Pregnancy or circumstances where radiation exposure requires particular caution.
- Certain coronary stents or complex existing disease where another test may answer the clinical question better.
Your referring clinician and imaging team should review these issues before the appointment.
Why Contrast Dye Makes a Difference
A standalone calcium score measures calcified plaque without contrast. CTCA uses intravenous contrast to highlight the channel within the coronary arteries. This makes it possible to examine plaque that would not be detected by calcium scoring alone, including non-calcified plaque, and to estimate narrowing along the vessel.
That does not mean that every non-calcified plaque is unstable or likely to cause a heart attack. Risk depends on multiple plaque characteristics and the wider clinical picture. The terms calcified and non-calcified describe imaging appearances, not a definitive prediction about what a particular plaque will do. CTCA can sometimes identify high-risk plaque features, but these require specialist interpretation and are not equivalent to a guaranteed prediction of future cardiovascular events.
CTCA vs Calcium Score: Which Test Is More Accurate?
Neither test is simply “more accurate” because they measure different aspects of coronary artery disease. A calcium score is designed to quantify calcified plaque. Its strength is its potential to refine cardiovascular risk assessment in selected people without symptoms.
A CT coronary angiogram provides more information about coronary anatomy, including non-calcified plaque and stenosis. It is more informative when the clinical question concerns suspected obstructive coronary disease. However, greater anatomical detail also comes with additional preparation, contrast administration and the possibility of incidental findings or follow-up investigations. The most appropriate test is the one that answers a justified clinical question.
CTCA and Calcium Score: Costs and Medicare in Australia
The two scans also differ in how they are funded. Standalone coronary calcium scoring: The Heart Foundation states that this test is not covered by Medicare, so patients generally pay the private fee charged by the provider.
CTCA: Medicare Benefits Schedule items 57360 and 57364 exist for eligible CT coronary angiography services. The rebate is not automatic. Specific clinical indications, referral requirements and other MBS conditions must be met.
For example:
- Item 57360 covers selected patients with stable or acute symptoms consistent with coronary ischaemia who meet the relevant low-to-intermediate-risk and other criteria.
- Item 57364 covers other specified clinical circumstances, including selected left ventricular dysfunction, suspected coronary anomalies, planned non-coronary cardiac surgery and certain assessments of bypass graft patency.
- Both items require a request from a specialist or consultant physician. A GP request alone does not meet the request requirement for these items.
A GP can still help assess your symptoms and refer you to a specialist or imaging service as appropriate. The availability of imaging and any private charges should be discussed before booking.
Is a Calcium Scan Always Cheaper Than CTCA?
A standalone calcium scan is generally simpler and often costs less than contrast-enhanced CTCA. However, prices vary by provider and location, and a cheaper test is not better value if it does not answer the clinical question. Equally, paying for a CTCA is not necessarily justified when a doctor only needs to clarify preventive risk in a suitable asymptomatic patient.
How Everlab Approaches CTCA and Calcium Scoring
Everlab offers CT Coronary Angiography as a member-only cardiovascular imaging service. It includes coronary plaque and calcification assessment as part of its advanced cardiac imaging pathway.
The current CTCA member price is $1,499. The exact scan components and inclusions, including how the calcium score is reported, can be confirmed with your Everlab doctor before booking. Instead of selecting a scan purely from a menu, members can discuss their history, risk factors, existing test results and goals with an Everlab doctor to determine whether advanced cardiac imaging is suitable. Everlab doesn't usually perform CTCA for people who have had coronary stents or who have new symptoms. They are referred to a cardiologist instead.
Why the SCOT-HEART 2 Trial Matters
Everlab refers to the SCOT-HEART 2 trial, which is studying whether CTCA-guided prevention improves outcomes for people without symptoms who have cardiovascular risk factors. The trial's participant profile is relevant to discussing which people researchers believe may benefit from further investigation. However, its enrolment criteria are not themselves clinical proof that routine CTCA screening prevents heart attacks in asymptomatic people.
A published nested substudy reported modest effects on some health behaviours and treatment uptake, but the main trial has not yet established whether this strategy reduces coronary events. Recruitment has closed and longer-term follow-up is ongoing. Everlab's doctors therefore assess CTCA suitability individually rather than present it as a universally recommended screening test.
What Happens After the Scan?
The imaging report may describe coronary plaque, the calcium score where obtained, estimated stenosis severity and incidental findings that warrant clinical follow-up.
The results need to be interpreted in context. A CTCA finding does not always require an invasive procedure, and a low calcium score does not remove the need to address smoking, blood pressure, cholesterol or other cardiovascular risk factors.
Depending on the findings, a clinician may recommend preventive treatment, further imaging, specialist review or continued monitoring. Changes to medication or further testing should be made with your treating healthcare professional.
Frequently Asked Questions
Is CTCA Better Than a Coronary Calcium Score?
Not universally. CTCA can show plaque and coronary narrowing in more detail, while calcium scoring can help refine preventive risk in selected people without symptoms. The best test depends on your symptoms, risk profile and the decision your doctor is trying to make.
Can I Get a Calcium Score Without a Referral?
Referral requirements vary by provider. Some private services allow booking without a traditional doctor referral, while many radiology centres require one. A clinical assessment is advisable because calcium scoring is not a recommended general screening test for everyone.
If I Already Had a Calcium Score, Do I Still Need CTCA?
Not necessarily. A calcium score and CTCA answer different questions. A calcium result by itself does not routinely justify CTCA, and further testing should depend on symptoms, overall cardiovascular risk and the clinical question.
Does a Zero Calcium Score Rule Out All Heart Disease?
No. It means no detectable calcified coronary plaque. It does not exclude non-calcified plaque, other forms of heart disease or the possibility of a heart attack. Persistent or concerning symptoms still require medical assessment.
Does CTCA Detect Soft Plaque?
Yes. CTCA can visualise non-calcified plaque as well as calcified and mixed plaque. However, the appearance of a plaque does not by itself determine whether it will cause a future heart attack.
Can CTCA Show Whether an Artery Is Blocked?
CTCA can identify and estimate narrowing of the coronary arteries. It can help assess whether significant stenosis is present, but it does not directly measure how much a narrowing affects blood flow. Your doctor may recommend functional testing or invasive angiography in certain cases.
Does a High Calcium Score Mean I Need a Stent?
No. A high score suggests substantial calcified plaque burden and increased cardiovascular risk. Treatment may involve managing cholesterol, blood pressure and other risk factors. Whether any intervention is appropriate depends on symptoms, coronary anatomy and further clinical assessment.
Can a Calcium Score Monitor Response to Cholesterol Medication?
Calcium scoring is not generally recommended as a routine way to monitor the response to lipid-lowering therapy. Calcification can change during treatment without mirroring the reduction in clinical risk. Treatment monitoring normally uses clinical review and other measures such as blood cholesterol.
Can CTCA or Calcium Scoring Replace Blood Tests?
No. Imaging and blood tests provide different information. Blood cholesterol, glucose and other relevant tests inform overall cardiovascular risk, while coronary imaging examines aspects of arterial plaque and anatomy. A clinician may consider both, but they are not interchangeable.
What If I Have Chest Pain Right Now?
If you have new, severe, prolonged or otherwise concerning chest pain, particularly with breathlessness, sweating or faintness, seek urgent medical assistance rather than booking an elective scan. In Australia, call 000 for an emergency.
Which Heart Scan Is Right for You?
For selected people without symptoms, a coronary calcium score may help refine cardiovascular risk after a conventional risk assessment when treatment decisions remain uncertain.
For people with symptoms or another appropriate clinical indication, CT coronary angiography may provide the detailed information about coronary plaque and stenosis that a calcium score cannot.
The decision should be made with a healthcare professional who can interpret your risk factors, medical history and symptoms. Everlab members can discuss whether CTCA fits into their wider cardiovascular assessment and confirm what is included before booking.
This article provides general information only. It is not a recommendation for routine CTCA or coronary calcium screening. CT imaging involves ionising radiation, and CTCA uses iodinated contrast. A referral is required for Everlab's CTCA pathway. Always discuss suitability, benefits, risks, alternative tests, and possible costs with your doctor.
Sources
- Australian Chronic Disease Prevention Alliance. 2023 Australian guideline for assessing and managing cardiovascular disease risk: reclassification factors.
- National Heart Foundation of Australia. Position statement on coronary artery calcium scoring for primary prevention of cardiovascular disease in Australia. Medical Journal of Australia, 2021.
- Heart Foundation. Coronary artery calcium scoring: patient information and Medicare coverage.
- Australian Government, Medicare Benefits Schedule. Item 57360 and Item 57364.
- Everlab. CT Coronary Angiography Test (CTCA).
- University of Edinburgh. SCOT-HEART 2 trial information.
- McDermott M, et al. SCOT-HEART 2 trial rationale and design. JACC: Cardiovascular Imaging, 2024.
- SCOT-HEART 2 investigators. CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy: A Nested Substudy. JAMA Cardiology, 2025.

















.avif)
